Inhibrx Biosciences Quote - INBX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

12.91

Bid

5.07

Ask

17.00

Volume

444

0.00 Day's Range 0.00

10.80 52 Week Range 39.79

Market Cap

186.884M

Previous Close

12.60

Open

Last Trade

12.9

Last Trade Time

04:25:52

Financial Volume

VWAP

Average Volume (3m)

82,597

Shares Outstanding

14,475,904

Dividend Yield

PE Ratio

-1.18

Earnings Per Share (EPS)

-10.71

Revenue

1.63M

Net Profit

-154.96M

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.inhibrx.com

Headquarters

Wilmington, Delaware, USA

Founded

Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was US$12.60. Over the last year, Inhibrx Biosciences shares have traded in a share price range of US$ 10.80 to US$ 39.79.

Inhibrx Biosciences currently has 14,475,904 shares outstanding. The market capitalization of Inhibrx Biosciences is US$182.40 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.18.

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer PR Newswire SAN DIEGO, Jan. 21, 2025 SAN DIEGO, Jan. 21, 2025...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1	-0.768639508071	13.01	13.89	12.45	69408	12.97540181	CS
4	-1.03	-7.38880918221	13.94	14.86	11.79	99776	13.23738768	CS
12	-1.12	-7.982893799	14.03	16.83	11.79	82597	14.161858	CS
26	1.85	16.7269439421	11.06	17.79	10.8	86797	14.78201685	CS
52	-24.77	-65.7377919321	37.68	39.79	10.8	274224	28.86986442	CS
156	-12.31	-48.8104678826	25.22	39.79	7.67	418662	24.88545836	CS
260	-6.79	-34.4670050761	19.7	50.97	7.67	335914	25.7902238	CS

INBX - Frequently Asked Questions (FAQ)

What is the current Inhibrx Biosciences share price?

The current share price of Inhibrx Biosciences is US$ 12.91

How many Inhibrx Biosciences shares are in issue?

Inhibrx Biosciences has 14,475,904 shares in issue

What is the market cap of Inhibrx Biosciences?

The market capitalisation of Inhibrx Biosciences is USD 182.4M

What is the 1 year trading range for Inhibrx Biosciences share price?

Inhibrx Biosciences has traded in the range of US$ 10.80 to US$ 39.79 during the past year

What is the PE ratio of Inhibrx Biosciences?

The price to earnings ratio of Inhibrx Biosciences is -1.18

What is the cash to sales ratio of Inhibrx Biosciences?

The cash to sales ratio of Inhibrx Biosciences is 111.6

What is the reporting currency for Inhibrx Biosciences?

Inhibrx Biosciences reports financial results in USD

What is the latest annual turnover for Inhibrx Biosciences?

The latest annual turnover of Inhibrx Biosciences is USD 1.63M

What is the latest annual profit for Inhibrx Biosciences?

The latest annual profit of Inhibrx Biosciences is USD -154.96M

What is the registered address of Inhibrx Biosciences?

The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Inhibrx Biosciences website address?

The website address for Inhibrx Biosciences is www.inhibrx.com

Which industry sector does Inhibrx Biosciences operate in?

Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PNBKPatriot National Bancorp Inc	US$ 2.36 (62.76%)	9.6M
MGOLMGO Global Inc	US$ 0.6727 (62.10%)	40.62M
BSBKBogota Financial Corporation	US$ 12.60 (58.63%)	6
LCNBLCNB Corporation	US$ 24.49 (57.39%)	47
FUSBFirst US Bancshares Inc	US$ 19.99 (56.17%)	1
FENCFennec Pharmaceuticals Inc	US$ 3.00 (-54.89%)	107
OCSOculis Holding AG	US$ 10.01 (-54.81%)	1
PLRXPliant Therapeutics Inc	US$ 3.54 (-54.56%)	150.92k
ANIKAnika Therapeutics Inc	US$ 9.01 (-49.35%)	8
FXNCFirst National Corporation	US$ 15.01 (-43.36%)	27
MGOLMGO Global Inc	US$ 0.6728 (62.12%)	40.64M
CYNCYNGN Inc	US$ 0.0795 (32.06%)	30.48M
NIVFNewGenIvf Group Ltd	US$ 0.1457 (8.73%)	11.55M
STBXStarBox Group Holdings Ltd	US$ 0.4949 (48.84%)	10.17M
PNBKPatriot National Bancorp Inc	US$ 2.36 (62.76%)	9.6M